Ham S W, Park J, Lee S J, Kim W, Kang K, Choi K H
Department of Chemistry, Chung-Ang University, Seoul, Korea.
Bioorg Med Chem Lett. 1998 Sep 22;8(18):2507-10. doi: 10.1016/s0960-894x(98)00411-9.
cdc25A and cdc25B were significantly overexpressed in certain types of cancers, and they represent potential therapeutic targets for anticancer drug. In this study, naphthoquinone analogs as cdc25A phosphatase inactivators were investigated.
细胞周期蛋白依赖性激酶25A(cdc25A)和细胞周期蛋白依赖性激酶25B(cdc25B)在某些类型的癌症中显著过表达,它们是抗癌药物潜在的治疗靶点。在本研究中,对作为cdc25A磷酸酶失活剂的萘醌类似物进行了研究。